Verified peer comparison
Karyopharm Therapeutics vs Parke Bancorp Financial Comparison
Direct answer
Karyopharm Therapeutics and Parke Bancorp are compared on the same basis.
The comparison uses 2025 results reported in USD.
Common metrics include Revenue, Operating income, Net income, Operating cash flow.
Alpha Vantage
Get free Karyopharm Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Karyopharm Therapeutics Revenue
- 146,067,000 USD
- Parke Bancorp Revenue
- 146,083,000 USD
- Karyopharm Therapeutics Operating income
- -90,707,000 USD
- Parke Bancorp Operating income
- 49,953,000 USD